Crossmark

Long-term Survival of Subcutaneous Anti-tumor Necrosis Factor Biological Drugs Administered Between 2008 and 2012 in a Cohort of Rheumatoid Arthritis Patients

Crossref DOI link: https://doi.org/10.1016/j.reumae.2018.09.001

Published Print: 2019-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Alvarez Rivas, Noelia

Vazquez Rodriguez, Tomas R.

Miranda Filloy, Jose A.

Garcia-Porrua, Carlos

Sanchez-Andrade Fernández, Amalia
License Information

Text and Data Mining valid from 2019-01-01
More Information

This article is maintained by: Elsevier

Article Title: Long-term Survival of Subcutaneous Anti-tumor Necrosis Factor Biological Drugs Administered Between 2008 and 2012 in a Cohort of Rheumatoid Arthritis Patients

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2018.09.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2017.04.007

Content Type: simple-article

Copyright: © 2017 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.

Document is current

Any future updates will be listed below